Gastrointestinal anthrax

Anthrax infection of the gastrointestinal tract that is usually acquired from the consumption of raw or undercooked meat from an infected animal.

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Drugs and Important Biological Agents (IBA) related to Gastrointestinal anthrax:

1.	ExotoxinsIBA 01/01/2002 - "Anthrax spores germinate after entering the body through skin abrasions (cutaneous anthrax) or by inhalation (inhalation anthrax) or ingestion (gastrointestinal anthrax) and multiply to produce two exotoxins which determine the virulence along with capsule. "
2.	Complement System Proteins (Complement)IBA 01/01/2013 - "We herein report the development of a murine model of gastrointestinal anthrax infection by gavage of vegetative Sterne strain of Bacillus anthracis into the complement-deficient A/J mouse strain. "
3.	Capsules (Microcapsules)IBA 01/01/2002 - "Anthrax spores germinate after entering the body through skin abrasions (cutaneous anthrax) or by inhalation (inhalation anthrax) or ingestion (gastrointestinal anthrax) and multiply to produce two exotoxins which determine the virulence along with capsule. "
4.	Anti-Bacterial Agents (Antibiotics)IBA 07/22/2004 - "Respiratory and gastrointestinal anthrax are characterized by rapid onset, fever, septicaemia and a high fatality rate without early antibiotic treatment. "

1.	Therapeutics 11/10/2003 - "We describe the clinical course of gastrointestinal anthrax, outline current therapy, review the microbiology of B anthracis, examine the epidemiology of natural outbreaks, discuss considerations regarding deliberate contamination, and summarize existing literature on the inactivation of spores present in food and water."